Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
33.52    0.54 (1.64%)
Bid:
33.51
Ask:
33.53
Spread: 0.02 (0.06%)
Market Cap: $56.99b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

Share Buyback Programme

12 May 2023 07:00

RNS Number : 1802Z
Compass Group PLC
12 May 2023
 

Legal Entity Identifier (LEI) No. 2138008M6MH9OZ6U2T68

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

SHARE BUYBACK PROGRAMME

 

Further to the half year results announcement made on 10 May 2023, Compass Group PLC (the "Company") announces that the programme to purchase up to £750 million of the Company's ordinary shares of 11 1/20 pence each ("Ordinary Shares") will commence on 12 May 2023 and will be completed this calendar year (the "Programme").

 

The purpose of the Programme is to reduce the share capital of the Company by returning surplus capital to shareholders.

 

The Company has entered into a non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc") to enable the purchase of up to £250 million of Ordinary Shares for the initial stage of the Programme between 12 May 2023 and 12 July 2023. JPMS plc will make its trading decisions in relation to the Company's Ordinary Shares independently of, and uninfluenced by, the Company. Ordinary Shares acquired by JPMS plc under the Programme will be on-sold by JPMS plc to the Company, with such on-sales to be carried out on the London Stock Exchange.

 

The Programme will be conducted within certain pre-set parameters. The Company's shareholders generally authorised it to purchase up to a maximum of 175,720,000 Ordinary Shares at its 2023 Annual General Meeting held on 9 February 2023, subject to certain limitations (the "General Authority"). The full balance of the General Authority is available to the Company in connection with the Programme, notwithstanding announcements dated 10 February 2023 to 3 April 2023 in connection with purchases of Ordinary Shares by the Company under the share buyback programme announced on 21 November 2022. The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the General Authority.

 

In addition to compliance with the terms of the General Authority, the Programme will also be conducted within the parameters prescribed by the Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 12 of the UK Listing Rules.

 

All Ordinary Shares purchased will be held in treasury and are expected to be used to meet obligations arising from employee share schemes, or other allocations of shares, to employees or directors. No purchases will be made in respect of the Company's American Depositary Receipts.

 

Enquiries

 

Investors:

Agatha Donnelly & Helen Javanshiri

+44 (0) 1932 573 000

Press:

Giles Robinson

+44 (0) 1932 963 486

Website:

www.compass-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSABMBTMTJBTAJ
Date   Source Headline
26th Nov 20182:35 pmRNSDirector/PDMR Shareholding
22nd Nov 20181:15 pmRNSDirector/PDMR Shareholding
21st Nov 20182:45 pmRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSFull Year Results
1st Nov 20182:15 pmRNSDirectorate Change
1st Nov 20187:00 amRNSTotal Voting Rights
11th Oct 20185:30 pmRNSDirector Declaration
11th Oct 20184:00 pmRNSDirectorate Change
1st Oct 201812:30 pmRNSBlock listing Interim Review
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20182:05 pmRNSDirector/PDMR Shareholding
6th Sep 20182:15 pmRNSEMTN Programme - Substitution of Issuer
6th Sep 20182:15 pmRNSEMTN Programme - Substitution of Issuer
6th Sep 20182:15 pmRNSEMTN Programme - Substitution of Issuer
3rd Sep 20184:25 pmRNSEuro Medium Term Note Programme - Final Terms
3rd Sep 201812:58 pmRNSTotal Voting Rights
1st Aug 20185:30 pmRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSThird Quarter Trading Update
20th Jul 20187:00 amRNSAnnual Update of Euro Medium Term Note Programme
4th Jul 20187:00 amRNSDirectorate Change
2nd Jul 20187:00 amRNSTotal Voting Rights
21st Jun 201812:07 pmRNSSecond Price Monitoring Extn
21st Jun 201812:02 pmRNSPrice Monitoring Extension
14th Jun 20185:00 pmRNSCompany Secretary Change
1st Jun 20187:00 amRNSTotal Voting Rights
18th May 20187:00 amRNSDirectorate Change
10th May 20184:45 pmRNSDirector/PDMR Shareholding
9th May 20187:00 amRNSHalf year results for the six months ended 31Mar18
1st May 20187:00 amRNSTotal Voting Rights
23rd Apr 201811:56 amRNSDirector Declaration
3rd Apr 20187:05 amRNSBlock listing Interim Review
3rd Apr 20187:00 amRNSTotal Voting Rights
23rd Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20183:05 pmRNSDirector/PDMR Shareholding
1st Mar 20185:20 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTotal Voting Rights
27th Feb 20181:35 pmRNSDirector/PDMR Shareholding
9th Feb 201812:50 pmRNSDirector/PDMR Shareholding
9th Feb 201810:03 amRNSResult of AGM
8th Feb 20187:00 amRNSAGM and Trading Update
1st Feb 20187:00 amRNSTotal Voting Rights
24th Jan 20187:00 amRNSRegional restatement
22nd Jan 20187:00 amRNSUS tax reform
2nd Jan 20187:05 amRNSDominic Blakemore
2nd Jan 20187:00 amRNSRichard Cousins
2nd Jan 20187:00 amRNSTotal Voting Rights
19th Dec 201710:43 amRNSRegional reporting structure - Replacement
18th Dec 201712:00 pmRNSRegional reporting structure
18th Dec 201710:05 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.